comparative effectiveness

The Institute for Clinical and Economic Review is seeking public comment on its plan to evaluate the cost-effectiveness of EGFR inhibitors and immunotherapies.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

This article has been updated to clarify information about NIH's Genetic Testing Registry.

The Personalized Medicine Coalition is urging its members to comment on how a draft methodology report from the Patient-Centered Outcomes Research Institute can better address comparative-effectiveness research involving molecularly targeted personalized treatments.

The Patient-Centered Outcomes Research Institute has released the first draft of its methodology report, which aims to improve the design of studies comparing the impact of differe

UBC's CER capabilities could help Sanofi opportunistically apply pharmacogenomic strategies in drug development and commercialize personalized medicines.

The firms will include pharmacogenomics and personalized medicine approaches as part of an alliance to develop drugs that are more effective in real-world settings.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.